This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Stopped OBI-888 no longer fulfills our goal of developing cost-effective therapies for cancer patients

Conditions

• Metastatic Solid Tumors
• Locally Advanced Solid Tumors

Interventions

• DRUG: OBI-888
• DRUG: OBI-888
• DEVICE: Globo H IHC Assay

Sponsor

OBI Pharma, Inc